tiprankstipranks
Beam Therapeutics, Inc. (BEAM)
NASDAQ:BEAM
US Market
Want to see BEAM full AI Analyst Report?

Beam Therapeutics (BEAM) Technical Analysis

2,290 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Beam Therapeutics, Inc.’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is -1.75, suggesting Beam Therapeutics, Inc. is a Buy.
Beam Therapeutics, Inc.’s (BEAM) 20-Day exponential moving average is 29.83, while Beam Therapeutics, Inc.’s (BEAM) share price is $31.39, making it a Sell.
Beam Therapeutics, Inc.’s (BEAM) 50-Day exponential moving average is 30.59, while Beam Therapeutics, Inc.’s (BEAM) share price is $31.39, making it a Sell.

Beam Therapeutics (BEAM) Pivot Points

Jul 27, 2026, 04:12 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.53
25.11
25.51
26.08
26.48
27.06
27.46
Fibonacci
25.11
25.48
25.71
26.08
26.45
26.68
27.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Jul 27, 2026, 04:12 AM
Period
Simple
Exponential
MA5
26.25Sell
26.42Sell
MA10
27.99Sell
28.02Sell
MA20
31.54Sell
29.83Sell
MA50
30.99Sell
30.59Sell
MA100
29.26Sell
29.74Sell
MA200
28.11Sell
27.60Sell
Beam Therapeutics, Inc.’s (BEAM) 10-Day exponential moving average is 28.02, while Beam Therapeutics, Inc.’s (BEAM) share price is $31.39, making it a Sell.
Beam Therapeutics, Inc.’s (BEAM) 100-Day exponential moving average is 29.74, while Beam Therapeutics, Inc.’s (BEAM) share price is $31.39, making it a Sell.
Beam Therapeutics, Inc.’s (BEAM) stock price is $31.39 and Beam Therapeutics, Inc.’s (BEAM) 50-day simple moving average is 30.99, creating a Sell signal.
Beam Therapeutics, Inc.’s (BEAM) stock price is $31.39 and Beam Therapeutics, Inc.’s (BEAM) 100-day simple moving average is 29.26, creating a Sell signal.
Beam Therapeutics, Inc.’s (BEAM) stock price is $31.39 and Beam Therapeutics, Inc.’s (BEAM) 200-day simple moving average is 28.11, creating a Sell signal.

Beam Therapeutics (BEAM) Technical Indicators

Jul 27, 2026, 04:12 AM
Name
Value
Implied Action
RSI (14)
31.45
Neutral
STOCH (9,6)
4.31
Buy
STOCHRSI (14)
2.71
Buy
MACD (12,26)
-1.75
Buy
ADX (14)
26.43
Neutral
Williams %R
-98.14
Buy
CCI (14)
-118.25
Buy
ATR (14)
2.11
-
Ultimate Oscillator
32.05
Neutral
ROC
-28.94
Sell
Beam Therapeutics, Inc.’s (BEAM) Relative Strength Index (RSI) is 31.45, creating a Neutral signal.
Beam Therapeutics, Inc.’s (BEAM) Trend Strength Indicator (ADX) is 26.43, creating a Neutral signal.
Beam Therapeutics, Inc.’s (BEAM) Commodity Channel Index (CCI) is -118.25, creating a Buy signal.
Beam Therapeutics, Inc.’s (BEAM) Price Rate of Change (ROC) is -28.94, creating a Sell signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Sell.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 31.45, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is -1.75, which suggests BEAM is a Buy.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 26.25, which suggests BEAM is a Sell.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 31.54, which suggests BEAM is a Sell.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 30.99, which suggests BEAM is a Sell.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 28.11, which suggests BEAM is a Sell.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -98.14, which suggests BEAM is a Buy.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is -118.25, which suggests BEAM is a Buy.